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Abstract	
  
Genital human papillomavirus infection is the most common sexually transmitted virus in the
United States, with almost 20 million Americans currently infected and an additional 6.2 million
becoming newly infected each year. Women rely strongly on their health care providers to
educate and comfort them regarding this distressing diagnosis. This study will use an online, selfcompletion questionnaire to obtain women’s opinions regarding their health care providers’
performances concerning the initial consultation after learning of their HPV diagnosis. Findings
from this study provided insight as to how women prefer receiving information from their health
care providers concerning their diagnosis of HPV. In addition, study findings provide suggestions
for improving clinical practices regarding HPV consultations in the Tri-cities area of East
Tennessee.
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Each year millions of women worldwide go to their health care providers and learn they
are infected with a sexually transmitted disease. The most prevalent viral diagnosis relates to a
relatively new virus called human papillomavirus, commonly referred to as HPV. Genital human
papillomavirus infection is the most common sexually transmitted virus in the United States, with
almost 20 million Americans currently infected and an additional 6.2 million becoming newly
infected each year (Friedman & Shepeard, 2007). HPV is diagnosed through cytological
examination as enlarged cervical cells with a clear zone around the nucleus, but most women see
it in the form of abnormal Papanicolaou (Pap) smear results.
Discovered in 1976, the Human Papillomavirus is a new addition to the long list of
universally accepted sexually transmitted infections. Since its initial discovery, over 100 strands
of the small, circular, double-stranded, non-enveloped deoxyribonucleic acid tumor virus have
been classified (Gelman, Nikolajski, Schwarz, & Borrero, 2011). The HPV DNA incorporates
itself into the target cell genome, activates oncogenes then proceeds to suppress the host cell’s
immune response. HPV protein products prevent cells from causing programmed cell death,
which leads to instability and unchecked cell growth (Fey & Beal, 2004).
Each of the different HPV strands have the capability to cause low-grade cell changes in
the cervix, but there are several that are more notable because of their tendency to cause highgrade cell abnormalities. “Low-risk” genotypes can cause benign or low-grade cervical tissue
changes and genital warts. There is an international consensus that “high-risk” genotypes,
including strands 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66, can eventually lead to
cervical cancer and have been associated with other cancers of the head and throat. Of the 100+
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HPV genotypes, there have been eight that frequently reoccur the most worldwide: 16, 18, 31, 51,
52, 53, 56, and 58 (Cutts, Franceschi, Castellsague, Sanjose, & Garnett, 2007). In 2006, the U.S.
Food and Drug Administration approved a quadrivalent vaccine that protects against strands 16,
18, 6, and 11—the culprits responsible for 70% of cervical cancer and 90% of genital warts. The
vaccine has since been recommended by the Advisory Committee on Immunization Practices for
use in females aged 9 to 26 years (Friedman & Shepeard, 2007).
Prevalence of HPV, is highest in young, sexually active women 18 to 25 years of age (Fey
& Beal, 2004). The human papillomavirus is primarily transmitted by genital skin-to-skin contact,
usually but not necessarily during sexual intercourse. Risk of HPV infection is directly linked to
the number of sexual partners that a woman has had recently and throughout the span of her life
(Cutts, Franceschi, Castellsague, Sanjose, & Garnett, 2007). Those who receive the vaccine
before the beginning sexual intercourse have a decreased risk of getting HPV, but are not
completely immune to all forms of the virus. Women who do become infected with HPV can
have high survival rates with routine tests and appropriate follow-up.
In truth, the human papillomavirus is a relatively new sexually transmitted disease and as
such there has been little information published regarding the psychosocial effects of being
diagnosed with HPV. It is vital that health care providers spend time educating women about
HPV prevention and thoroughly discussing the proposed plan of care following diagnosis. before
they get it and thoroughly discussing it with those who have already become infected. It is
estimated that as many as 80% of sexually active women will be positive for HPV at some point
in their lives and health care providers need to be mindful that a large portion of those women are
utterly unaware about what HPV is. (Akyuz, Yilmaz, Yenen, Yavan, & Kilic, 2011) Although
health care providers may recognize that generally only one-fifth of all untreated human
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papillomavirus-associated lesions will lead to cervical cancer, the women just discovering that
they have a sexually transmitted disease will not (Fey & Beal, 2004). Ultimately, even with the all
of the precautionary care and treatments available, the biggest factors in preventing any adverse
outcomes from HPV are the health care providers caring for those at risk.

Overview	
  of	
  the	
  Study	
  
Genital human papillomavirus is the most common sexually transmitted virus in the United States
with the rates becoming higher and higher each year. Women strongly rely on their health care
providers to educate and comfort them regarding this distressing diagnosis. This study will be
completed through a series of open-ended online questions, conducted anonymously, to obtain
infected women’s perceptions of their healthcare provider’s performance concerning the initial
consultation after receiving the news of their HPV diagnosis. Questions asked in the survey will
focus on exposing deficiencies in the health care consultation and inquire as to changes women
would have liked regarding their HPV diagnosis. The results of this study will offer insight in to
what women would appreciate hearing from their health care providers concerning their diagnosis
and therefore possibly improve clinical practices regarding HPV in the Tri-Cities area of East
Tennessee.

Objectives	
  
The objective of this study is to determine, through an online survey, whether
women infected with the human papillomavirus are satisfied with their health care consultation
subsequent to their initial diagnosis. Questions in the survey focus specifically on obtaining
personal accounts from women concerning the first meeting with their health care provider
regarding their HPV diagnosis. The information obtained in this study should illuminate how
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deeply women’s lives are affected by this sexually transmitted infection and also how effectively
clinicians are addressing the psychosocial aspect of the diagnosis.

Hypothesis	
  
	
  

Health care providers play a detrimental role in providing and promoting health education

to their patients. In addition, health care providers are privy to intimate details of patients’ lives,
especially when dealing with the sensitive topic of sexually transmitted infections. Health care
providers who act as both an educator and a confidant are more likely to have an impact on their
patients than those who simply educate. Women diagnosed with HPV whose health care
providers gave thorough explanations about the virus and addressed the impact the diagnosis will
have on future sexual relationships will be more comfortable with HPV than those whose health
care providers did not.

Literature	
  Review
The literature on the human papillomavirus is rather abundant for a disease discovered less
than fifty years ago. The largest dilemma concerning the availability of the literature is, because
HPV is a relatively new virus, the information is constantly being updated and older studies are
being proven completely incorrect or erroneous. A plethora of articles have been published about
the biological structure of HPV and how it affects the cervical cells of those who become
infected. The American Family Physician journal has had several articles that contain very
thorough explanations of what HPV is and does to the female body. FT Cutts, et al, (2007)
published an article in the Bulletin of the World Health Organization about human papillomavirus
and the current vaccines approved for its prevention. In the article they discuss the numerous
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different strands of HPV and the methods by which the vaccines help protect the human body
against them.
Newer studies are now beginning to tackle the issue of public knowledge and perceptions
of the human papillomavirus. A study done in 2006 by Allison L. Friedman and Hilda Shepeard
focused on obtaining the level of knowledge about HPV and the opinions associated with it. They
used 315 participants separated into 35 focus groups to develop a set of thematic results which
summarized the overall opinions of each group. Categories of questions ranged from knowledge
about epidemiology to STD-associated stigmas regarding HPV. Their study found that most of
the participants had heard about STD related genital warts and were able to explain that most
STDs are treatable. However, there were large misconceptions that men are affected by genital
warts more frequently and that all forms of genital warts are related to herpes. Overall, the study
found there was low HPV awareness across all of the groups and in general only one or two
people from each group had ever heard of the virus.
A more recent study utilized a couple of outpatient gynecology clinics in Turkey to obtain
information about women’s overall awareness of the human papillomavirus (Akyuz, Yilmaz,
Yenen, Yavan, & Kilic, 2011). Using a multiple-choice questionnaire, the study surveyed a total
of 229 Turkish women about their knowledge and attitudes towards the vaccines, tests, and the
virus itself. After analysis, this study showed that although most women were aware of HPV,
most did not know that it is a sexually transmitted. From this study the authors concluded that
even women positive for HPV have insufficient knowledge about the virus and the health risks
associated with it. 	
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Catherine Cook, a researcher at the University of Auckland in New Zealand, conducted indepth research on the psychosocial effects of the human papillomavirus and other sexually
transmitted infections. In 2009 she published her doctoral thesis that analyzed a series of
interviews she conducted via email in 2007, which were used to gauge the opinions of women
diagnosed with HPV and other viral STIs about their clinical experiences. Through her qualitative
research she found that although many clinicians are able to de-sexualize gynecological
examinations and view the cases as purely “objective,” many patients cannot. She found that
women often view clinical consultations regarding sexually transmitted diseases as more taboo
than other conditions and thus perceive them as a “moral burden.” The research found that if
health care providers followed an objective and routine protocol for their examinations, women
would not risk asking anything inappropriate:
“For many women patients, to ask a question that falls outside the parameters of the
appropriate knowledge-base already established by the clinician is to risk being
constituted as morally questionable, as a ‘risky’ woman rather than a ‘normal’ woman. To
ask a question tells the Confessor something about one’s ‘true nature.’” (Cook, The
Pedagogy of the Clinic: Health Professionals and Women with Viral Sexually Transmitted
Infections, 2009, p. 131)
Overall, the thesis concluded that health care providers should initiate questions about the
diagnosis and female sexuality with each patient, especially if they have been diagnosed with a
sexually transmitted infection.
In her follow up study, Catherine Cook further examined the email interviews she
conducted in 2007. Through literary analysis she determined that the majority of medical research
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focuses on female anxiety regarding the examination, but rarely does research focus on the
influence of the health care providers’ practices in adding to the apprehension. During her
thematic analysis of the qualitative data she identified that women are more likely to perceive the
“normal” gynecological examination differently and become more vulnerable subsequent to
learning of their sexually transmitted infection diagnosis. She concluded that when clinicians put
an emphasis on “normalizing” somewhat uncomfortable medical procedures they ultimately
discourage women from participating in vital follow up testing.

Methods
Population	
  and	
  Sample	
  
To obtain the most authentic results, only female individuals over the age of 18 who have
been formally diagnosed with human papillomavirus were included in this study. Women must
have had their initial post-diagnosis consultation in the Tri-Cities area of East Tennessee to be
included in the qualitative portion of the survey. Recruitment for the study consisted of flyers
placed in various locations throughout the Tri-Cities area of East Tennessee such as Health
Departments, gynecology offices, public libraries, and campus health centers. An email was also
distributed to all students of East Tennessee State University, which contained information and a
link to the online survey. Any individual who expressed a desire to participate and meets the
inclusion criteria is eligible to participate in the study.
Instruments	
  
The instrument used for this study will be a self-completion questionnaire consisting of
two parts. The first part of the survey will include demographic data used for statistical purposes
only. These questions will be asked in a closed question format with a predetermined set of
responses to choose from. Questions will inquire about gender, age, geographical area, time since
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HPV diagnosis, and number of health care providers consulted about the HPV diagnosis. The
second portion of the survey will include several questions taken from the study performed in
2009 by Catherine Cook. These questions were deemed as being highly appropriate for use in this
study and delivered thorough and in-depth responses from participants in the first study. These
questions will be open format questions in which respondents will be able to voice their detailed
and factual recollections.
Data	
  Collection	
  
In order to ensure the comfort and confidentiality of the participants, the research study
was conducted entirely online. Utilizing SurveyMonkey.com to administer the survey questions
ensured that each of the participants were able to remain anonymous, which allowed individuals
to speak more freely if they wished to. SurveyMonkey.com creates a secure web link with Secure
Sockets Layer encryption. The SSL encryption creates a cryptographic system that secures a
connection between a client and a server. By using this website there was absolutely no way to
trace information back to a specific server. SurveyMonkey.com reduced the risk of inflicting
psychological harm that could have been sustained from feeling pressured or forced into
discussing intimate information from face-to-face interviews.
The consent process began as soon as the participant visited the survey URL. The first
“question” of the survey served as an electronic consent form. In-depth information about the
survey was provided and the participant was asked if they still wished to continue forward with
the anonymous online survey. If the participant selected that they did not wish to participate, they
were re-directed to a page thanking them for taking the time to read about the study and that they
would be asked no further questions. If the participants selected that they were interested in
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continuing with the study, they were immediately advanced to the demographic portion of the
survey.
Once the participants agreed to participate in the study they were directed through a series
of online questions. The first four questions of the survey acted as a demographic,
inclusion/exclusion assessment. If the participant was not eligible to answer the qualitative
questions, he or she would be re-directed to a conclusion page thanking them for their time. If the
participants were eligible, they would proceed to the focused HPV portion of the survey. These
questions were both open and close ended; inquiring in to the health care experience they received
regarding their HPV diagnosis. If any of the questions made the participant feel uncomfortable
they were allowed to omit the question and continue with another question. After they completed
the survey they were re-directed to a completion page, which thanked them for their participation
and informed them that there were no more questions.
Data	
  Analysis	
  
Data analysis for this study consisted of both statistical and thematic review of the
collected data. Quantitative survey responses were entered into an Excel spreadsheet for grouping
purposes. Data was checked for input errors and corrected. IBM Statistical Product and Service
Solutions (SPSS) version 20.0 was used to analyze the data after being transferred from the Excel
spreadsheet.	
  The qualitative data was analyzed thematically under the standards developed by
Braun and Clarke. Under these standards, the information from the study was reviewed in six
distinct steps: familiarization with the data collected; generating initial codes; searching for
themes; reviewing themes; defining and naming themes; and then the production of the report.
Both a qualitative data analysis expert and a women’s health specialist reviewed the material to
ensure the relevancy and validity of the results. The thematic analysis examined and pinpointed
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trends in the data collected; this form of analysis was useful in producing a compilation of topics
that needed to be addressed by health care providers.

Results	
  
Qualitative	
  Responses	
  
On the survey conclusion date of October 11th, 2013, a total of 233 individuals had taken
the online survey regarding HPV. To ensure validity of the qualitative responses receieved, each
of the demographic questions doubled as inclusion/exlcusion criteria for individuals such as those
who were male, had not been diagnosed with the human papillomavirus, or had been diagnosed
outside of the Tri-Cities area of East Tennessee. SurveyMonkey was instructed to automatically
exclude individuals who did not meet these criterion for the suvery, as well as participants who
opted out of answering the demographic questions.
Table 1. Consent
Women with HPV and your Healthcare Experiences
Do you consent to participate in this study?
Response

Response

Percent

Count

Yes

88.0%

205

No

12.0%

28

Answer Options

Answered question

233

Skipped question

0

Missing

0

Total

233

The initial question in the survey was an electronic consent. Individuals who responded
that they did not consent, 28 participants (12%), did not progress through the rest of the survey
and were included in the overall “missing” total for Table 2 and the remainder of the results.
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Table 2. Gender
What is your gender?
Response

Response

Percent

Count

Female

91.6%

186

Male

8.4%

17

Answer Options

Answered question

203

Skipped question

2

Missing

28

Total

233

The first actual question of the survey inquired as to the gender of the participant taking
the survey. The 17 individuals (8.4%) who answered “Male,” as well as the 2 individuals who
skipped the question, were not allowed to progress through the survey and were therefore
included in the “missing” total for Table 3 and the remainder of the results.
Table 3. HPV Diagnosis
Have you ever been diagnosed with Human Papillomavirus (HPV)?
Response

Response

Percent

Count

Yes

35.1%

65

No

64.9%

120

Answer Options

Answered question

185

Skipped question

1

Missing

47

Total

233

Of the females who consented to take the survey, 35.1% (65 participants) had been
diagnosed with the human papillomavirus. One individual opted to leave the question blank and
was therefore included in the “missing” total, as were the 120 participants without HPV.
Table 4. Age
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Which category below includes your age?
Response

Response

Percent

Count

17 or younger

0.0%

0

18-20

7.7%

5

21-23

20.0%

13

24-26

26.2%

17

27-29

9.2%

6

30-40

29.2%

19

40 or older

7.7%

5

Answer Options

Answered question

65

Skipped question

0

Missing

168

Total

233

Of the 65 individuals diagnosed with HPV, all 65 reported an age. Although women under
the age of 18 who are diagnosed with HPV were relevant to this study, they were to be excluded.
The 5 females over the age of 40 diagnosed with HPV (7.7% of those who responded) were also
excluded from taking the qualitative portion of the survey and were included in the overall
“missing” total.
Table 5. Location of Diagnosis
Response

Response

Percent

Count

Bristol, TN

8.5%

5

Bristol, VA

1.7%

1

Elizabethton, TN

1.7%

1

Johnson City, TN

28.8%

17

Kingsport, TN

6.8%

4

Outside of East Tennessee

52.5%

31

Answer Options

Answered question

59

Skipped question

1

Missing

173

Total

233
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In the last exclusion eligible question, participants were asked the location of their initial
HPV diagnosis. Individuals were given five cities classified as being within the “Tri-Cities” area
of East Tennessee and Southeast Virginia. The 31 participants (52.5%) of females diagnosed with
HPV outside of East Tennessee were ineligible to take the qualitative portion of the survey.
Table 6. Healthcare Providers & Impact
How big an impact have you found doctors and nurses to have on your overall
experiences to date living with HPV?
Response

Response

Percent

Count

Big impact

4.5%

1

Some impact

36.4%

8

No opinion

27.3%

6

Little impact

18.2%

4

No impact

13.6%

3

Answer Options

Answered question

22

Skipped question

6

Missing

205

Total

233

The very last question of the survey was also a quantitative question, which asked
participants how big of an impact they felt their health care providers had on their overall
experiences of living with HPV. This question was answered by 22 of the 28 eligible participants,
8 of which (36.4%) stated that their healthcare providers had some impact on their experience.
Qualitative	
  Findings	
  
The qualitative portion of the survey allowed for the participants to voice their thoughts
anonymously and truthfully. Participants were asked a series of seven open-ended questions that
sought in-depth descriptions of their experiences with healthcare professionals and their feelings
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regarding their diagnosis. Several trends appeared throughout the responses that can be
categorized by one major theme.
Unmet	
  Client	
  Needs	
  
	
  	
  

Based on the responses provided through the online SurveyMonkey survey, it was

apparent that the main theme was ‘unmet client needs.’ Two distinct subthemes also emerged in
the process of analyzing data, which are explained in detail later in this section.
Figure 1. Theme Analysis

	
  

Figure 1 is a visual interpretation of the theme and the two subthemes developed through the
responses given for the qualitative portion of the survey. With the major theme being, ‘Meeting
Client Needs,’ the quotes show trends in the responses that were provided which link to both of
the subthemes, ‘Unanswered Questions’ and ‘Individualized Needs.’
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Unanswered	
  Questions	
  
	
  

A number of respondents found that their diagnosis of human papillomavirus left them

“nervous,” “frightened,” and “shaken up.” These women most often stated that they were notified
of their diagnosis via a letter sent in the mail informing them of their “abnormal” Papanicolaou
test results. The women that did receive phone calls from their gynecology office spoke to an
uninformed office staff member rather than their actual healthcare provider. One of the
individuals stated:
When the office staff member called me she was unable to answer any of my questions about
HPV. I was frustrated. I called back to ask more questions, but the staff member was unable
to answer anything. I was told to come back in three months. I then called my friend who’s a
women’s health nurse practitioner to get information.

Following suit, another participant who had the same experience suggested that only health care
professionals make phone calls to patients because the office secretaries add to the stress of the
new diagnosis.
I would also encourage health professionals to not have staff members that can’t answer
questions call patients with results. I was scared and freaked out by the diagnosis and the
person on the phone couldn’t give me any information about what that meant or how it
would be treated.

Some of the women who received the letter in the mail attempted to contact their clinician in an
attempt to learn more about their diagnosis but felt were poorly treated for doing so.
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After getting the letter in the mail I had to get into contact with my gynecologist to learn
more about what the lab results meant. She did not call me back for a couple of days and
then she was very short with me when I asked questions about it.

The theme of unanswered questions does not end with the initial diagnosis. Women in the
survey reported that they still felt uneducated about their diagnosis months after they had
received their abnormal results. Some women were even unsure of how exactly they were
diagnosed with HPV:
For me, no one had told me about HPV when I was having the pap test done. I still to
this day do not know if you can find out if you have HPV through a pap test or if it has
to be a specific test for HPV.

In addition to medical questions, most respondents had unanswered questions regarding
their sexual relationships. Women in the study were often seeking answers about their
relationships that could not be directly answered by laboratory results or a medical consultation.
Information pertaining to relationship fidelity and sexuality were identified by many of the
participants as topics health care providers should address in the initial consultation. One woman
stated:
I think it is difficult to ask questions regarding the length of time I’ll have the STD and
also about what it means for my current/future sexual partners.

The concern for contamination of others was reiterated throughout the open-ended responses as a
topic that needed to be discussed by health care providers in the initial consultation for the new
HPV diagnosis. Another participant was worried about what it would mean for her current
relationship as well:
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It’s hard to ask about spreading the disease because once you know you have a
responsibility to be careful and tell your partner, which was really hard for me since I had
just started dating the man of my dreams.

These responses from the study reiterate that a new diagnosis of human papillomavirus is stressful
and can leave the patient extremely worried. In addition, most participants felt that they were not
receiving adequate information regarding their diagnosis nor were they receiving any empathy
from their health care providers regarding their situation.
Individualized	
  Needs	
  	
  

The second theme that was apparent from the collected data was the difference of the
needs of each woman in the study. The new diagnosis of HPV combined with numerous other life
stressors leaves these individuals vulnerable and confused. Women in the study all sought
different things from their health care provider and the only commonality between these needs
was that none of them were met. In the responses some women stated that they wanted their
health care provider to tell them “everything they know about HPV and be straight forward,”
whereas others felt that a good majority of the information was irrelevant. One participant stated:
There are way too many scare tactics out there with HPV. I would want a health
professional to discuss how common it is and how it typically clears on its own.

Other women also supported the assumption that health care professionals try to use “scare
tactics” to coerce women into agreeing to do unnecessary procedures regarding their diagnosis.
The health department makes you think you have cancer when they inform you that you
have HPV. I don’t think they should scare us into thinking we need unnecessary
procedures for mild dysplasia.
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Yet other participants were disappointed that they weren’t given more education or support
regarding their diagnosis. They felt their health care professionals were unfeeling of their
situation. One participant was extremely affected by the perceived insensitivity of her health care
provider, writing:
I sat there feeling gross and helpless while the doctor seemed not to care. I was crying and
she made me feel like complete shit by her attitude. I had so many questions that she did
not answer. Granted, I did not ask many questions at the time because I was still shocked
to learn I had an STD. I had recently been sexually assaulted by two different guys at a
party and was feeling the anger and hurt all over again. While I don’t remember if she
knew this information, I really needed some emotional support and she seemed overall
unfazed by my diagnosis. She had me go ahead and get the Gardasil shots and prescribed
me a cream to get rid of the warts.

Although this situation was not the norm for most of the participants, other women were also
affected by the perceived lack of empathy given by their health care providers. One participant
was so deeply affected by the attitude of her healthcare provider she chose to go to someone else:
My first experience was very different than anything else in that I felt so lost and confused
while the doctor acted like she saw this all the time and it was nothing new to her. She was
so cold about the whole thing; I immediately switched to a different doctor.

Another participant was upset because, although she knew that her healthcare provider frequently
saw HPV patients, she felt the conversation was not what she needed it to be. She stated,
I felt that my doctor was too casual about the conversation, perhaps because of his
experience in seeing these infections clear on their own.
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When asked about what ‘prescription’ participants would give health professionals about and
ideal consultation process in relation to a new human papilloma diagnosis one participant wrote,
I think you have to be compassionate. Just because this is an STD that most people have
(men just don’t know it) doesn’t change how it makes you feel. Plus they may not know
each woman’s circumstances.

The majority of participants in this study believed that their health care providers were
uninformed of their needs and thus were unable to connect with them emotionally. A few
participants thought highly of their health care providers because they were “comforting” and
treated them “with great professionalism and respect.”

Discussion	
  
Although there were several positive comments about the experience of the initial human
papillomavirus consultation, for the most part these responses illuminate that there is a large
psychosocial component of the consultation that is being neglected by women’s health providers.
Due to the sensitive nature of the topic, women often felt as if they were completely alone in
coping with their new diagnosis and their healthcare providers completely avoided the
opportunity to act as a confidant. Most often these women were dealing with numerous issues
separate from the diagnosis, which added to the stress of learning they had a sexually transmitted
disease. Some women were frustrated, even angry, with their healthcare providers for not being
more thorough with explanations and acting nonchalant about the effect this would have on their
wellbeing.
In general, this study is rather unlike the majority of most literature available at this point
in time. Whereas other studies sought to learn more about the overall knowledge and perception
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of the human papillomavirus, very few have tackled the psychosocial component of the virus. The
2009 study done by Catherine Cook titled, "The Pedagogy of the Clinic: Health Professionals and
Women with Viral Sexually Transmitted Infections,” focused mainly on genital herpes but sought
the same type of information. She found that although clinicans most commonly adopt a
“nonjudgemental, sex positive approach” to the consultation, women felt unable to seek
additional help. Her conclusion is similar to the interpretations made in this study regarding the
unmet client needs. Women feel that by having a clinican use the minimalistic method when
addressing the human papillomavirus they are not getting all the answers they need concerning
the diagnosis nor are they receiving adequate emotional support.
Implications	
  for	
  Nursing	
  Practice	
  
Nurses working with women newly diagnosed with the human papillomavirus should be
thoroughly educated on the topic and its progression. Based on the findings in this study, most of
the women who were frustrated with their clinical experiences were disappointed by their
inability to learn more about their diagnosis. Health care providers should experiment with
addressing both the medical ‘normalcy’ of the human papillomavirus while also discussing the
potential for these infections to disrupt women’s personal, sexual and social relationships. The
current practice of discrediting the stigma of HPV on scientific grounds does not translate
smoothly for women or transform their view.
Also based on the responses in this study, it seems appropriate for health care providers to
initiate questions about the effects of the diagnosis upon women’s lives, especially addressing the
impact upon both current and future sexual relationships. These questions indicate to the patient
that the healthcare provider is okay with talking about HPV and open to all sexual habits. This
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recommendation does not mean that health care providers need to become ‘sex therapists.’ It
would be acceptable to ask simple questions, such as, “have there been any changes within your
sexual relationships since you’ve been diagnosed with HPV?” which may then guide clinicians in
the incorporate of medical ‘facts’ where they specifically relate to each individual’s
circumstances.
It would also be helpful for healthcare providers to offer materials regarding the human
papillomavirus prior to the initial consultation. The women in the study most frequently learned
of their diagnosis via a letter in the mail, which was then followed by a call from a receptionist or
office nurse who was unable to answer any case specific questions. While it would be preferable
for the diagnosing provider to individually call each of his or her clients newly diagnosed with
HPV, this is highly unrealistic due to the volume of work healthcare providers are assigned.
Instead, it may be helpful to mail several informational brochures or a list of websites in which
the individual can independently learn about her or his diagnosis. It is useful for healthcare
providers to demonstrate knowledge of internet resources and to recommend specific websites.
Women will use the internet regardless of what they are told via the phone or a consultation, so
showing an awareness will more likely enable women to disclose internet use to clinicians.

Limitations	
  
There are a number of limitations present in this study, which may provide direction for
future research studies. It may have been useful for the purposes of this study to interview
healthcare providers in addition to the individuals diagnosed with HPV in order to receive a more
balanced perspective on the initial consultation. It would have also been relevant to have used a
different form of communication to receive the responses, because although the internet can allow
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for more open communication it would have been theoretically better to perform interviews via
email.
The largest limitation of this study is that it is not necessarily generalizable to other areas
outside of East Tennessee and Southeast Virginia. Due to the exclusion of those diagnosed
outside of this area the results are only applicable to healthcare providers in this area. A larger
study that examines a wider variety of ethnic, religious, and cultural backgrounds would be
beneficial in confirming or disproving the results found through this study.
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Survey	
  Questions	
  
1. Gender
a. Female
b. Male
2. Have you ever been diagnosed with Human Papillomavirus (HPV)?
a. Yes
b. No
3. Which category below includes your age?
a. 18 – 20
b. 21 – 23
c. 24 – 26
d. 27 – 29
e. 30 – 40
f. 40 or older
4. In what area were you living when you learned of your HPV diagnosis?
a. Bristol, TN
b. Bristol, VA
c. Elizabethton, TN
d. Johnson City, TN
e. Kingsport, TN
f. Outside of East Tennessee
5. Can you tell me about when and how you came to find out about your HPV diagnosis?
6. What do you recall about the initial process of consulting a health professional about your
diagnosis of HPV?
7. How similar or different was the HPV consultation process compared to experiences
consulting health professionals about other conditions?
8. What questions, if any, are difficult to ask health professionals about HPV? Why?
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9. Are there any topics you would find helpful for a health professional to initiate in a
conversation related to HPV that would make you more comfortable?
10. Based on your experiences, what is the ‘prescription’ you would like to give health
professionals about an ideal consultation process in relation to women with HPV? What
would you want for them to change about the whole process?
11. Have health professionals ever initiated a conversation with you about the possible effects
of living with HPV (both the physical and emotional impact) on sexual relationships?
12. How big an impact have you found doctors and nurses to have on your overall experiences
to date living with HPV?
a. Big Impact
b. Some Impact
c. No opinion
d. Little Impact
e. No Impact
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